ResearcherHarbin Medical UniversityActive in the last 2 years
Ying Yan
Matched on ORCID iD 0000-0002-3546-3991; OpenAlex author ID A5030191700; NIH RePORTER profile ID 8878285. Sources: OpenAlex.
Their work
- Papers
- 13 (first author 1, last author 2)
- Trials
- 0
- Grants
- 1
- Labs led
- 1
- Collaborators
- 31
2014: 2 papers · 2015: 2 papers · 2016: 2 papers · 2017: 2 papers · 2018: none · 2019: 1 paper · 2020: 1 paper · 2021: none · 2022: 2 papers · 2023: none · 2024: 1 grant · 2025: none · 2026: 1 paper
Papers 13
- Rac1 GTPase Regulates the SCFβTrCP-Mediated Degradation of Claspin and the Cellular Response of Pancreatic Cancer Cells to Gamma Rays. Co-author DOI 10.3390/cancers18121908↗
- The GSK3 kinase and LZTR1 protein regulate the stability of Ras family proteins and the proliferation of pancreatic cancer cells. Co-author DOI 10.1016/j.neo.2022.01.002↗
- The histone deacetylase inhibitor M344 as a multifaceted therapy for pancreatic cancer. Co-author DOI 10.1371/journal.pone.0273518↗
- Correction: Inhibition of RAC1 GTPase sensitizes pancreatic cancer cells to γ-irradiation. Co-author DOI 10.18632/oncotarget.27450↗
- PR55α regulatory subunit of PP2A inhibits the MOB1/LATS cascade and activates YAP in pancreatic cancer cells. Last author DOI 10.1038/s41389-019-0172-9↗
- Biological determinants of radioresistance and their remediation in pancreatic cancer. Co-author DOI 10.1016/j.bbcan.2017.02.003↗
- Inhibitors of telomerase and poly(ADP-ribose) polymerases synergize to limit the lifespan of pancreatic cancer cells. Co-author DOI 10.18632/oncotarget.19410↗
- PR55α Subunit of Protein Phosphatase 2A Supports the Tumorigenic and Metastatic Potential of Pancreatic Cancer Cells by Sustaining Hyperactive Oncogenic Signal… Last author DOI 10.1158/0008-5472.can-15-2119↗
- Sensitization of Radiation or Gemcitabine-Based Chemoradiation Therapeutic Effect by Nimotuzumab in Pancreatic Cancer Cells. Co-author DOI 10.1177/1533034615585209↗
- Rac1 GTPase in pancreatic cancer. Co-author DOI 10.18632/aging.100804↗
- Novel HER3/MUC4 oncogenic signaling aggravates the tumorigenic phenotypes of pancreatic cancer cells. Co-author DOI 10.18632/oncotarget.3912↗
- Telomerase inhibitor Imetelstat (GRN163L) limits the lifespan of human pancreatic cancer cells. First author DOI 10.1371/journal.pone.0085155↗
- Inhibition of RAC1 GTPase sensitizes pancreatic cancer cells to γ-irradiation. Co-author DOI 10.18632/oncotarget.2500↗
Grants 1
Closest collaborators
The 25 strongest of 31 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Michel M. Ouellette · 10 shared papers, 2014–2026 · strength 1.21
- Paper Rac1 GTPase Regulates the SCFβTrCP-Mediated Degradation of Claspin and the Cellular Response of Pancreatic Cancer Cells… DOI 10.3390/cancers18121908↗
- Paper The GSK3 kinase and LZTR1 protein regulate the stability of Ras family proteins and the proliferation of pancreatic can… DOI 10.1016/j.neo.2022.01.002↗
- Paper Correction: Inhibition of RAC1 GTPase sensitizes pancreatic cancer cells to γ-irradiation. DOI 10.18632/oncotarget.27450↗
- Surinder K. Batra · 9 shared papers, 2014–2026 · strength 1.08
- Paper Rac1 GTPase Regulates the SCFβTrCP-Mediated Degradation of Claspin and the Cellular Response of Pancreatic Cancer Cells… DOI 10.3390/cancers18121908↗
- Paper The GSK3 kinase and LZTR1 protein regulate the stability of Ras family proteins and the proliferation of pancreatic can… DOI 10.1016/j.neo.2022.01.002↗
- Paper Correction: Inhibition of RAC1 GTPase sensitizes pancreatic cancer cells to γ-irradiation. DOI 10.18632/oncotarget.27450↗
- Neha Chaudhary · 2 shared papers, 2022–2026 · strength 0.56
- Paper Rac1 GTPase Regulates the SCFβTrCP-Mediated Degradation of Claspin and the Cellular Response of Pancreatic Cancer Cells… DOI 10.3390/cancers18121908↗
- Paper The GSK3 kinase and LZTR1 protein regulate the stability of Ras family proteins and the proliferation of pancreatic can… DOI 10.1016/j.neo.2022.01.002↗
- Parthasarathy Seshacharyulu · 5 shared papers, 2015–2022 · strength 0.45
- Paper The GSK3 kinase and LZTR1 protein regulate the stability of Ras family proteins and the proliferation of pancreatic can… DOI 10.1016/j.neo.2022.01.002↗
- Paper PR55α regulatory subunit of PP2A inhibits the MOB1/LATS cascade and activates YAP in pancreatic cancer cells. DOI 10.1038/s41389-019-0172-9↗
- Paper Biological determinants of radioresistance and their remediation in pancreatic cancer. DOI 10.1016/j.bbcan.2017.02.003↗
- Katrina M. Burchett · 4 shared papers, 2014–2020 · strength 0.32
- Paper Correction: Inhibition of RAC1 GTPase sensitizes pancreatic cancer cells to γ-irradiation. DOI 10.18632/oncotarget.27450↗
- Paper Inhibitors of telomerase and poly(ADP-ribose) polymerases synergize to limit the lifespan of pancreatic cancer cells. DOI 10.18632/oncotarget.19410↗
- Paper Telomerase inhibitor Imetelstat (GRN163L) limits the lifespan of human pancreatic cancer cells. DOI 10.1371/journal.pone.0085155↗
- Ashley L. Hein · 4 shared papers, 2014–2020 · strength 0.32
- Paper Correction: Inhibition of RAC1 GTPase sensitizes pancreatic cancer cells to γ-irradiation. DOI 10.18632/oncotarget.27450↗
- Paper PR55α regulatory subunit of PP2A inhibits the MOB1/LATS cascade and activates YAP in pancreatic cancer cells. DOI 10.1038/s41389-019-0172-9↗
- Paper PR55α Subunit of Protein Phosphatase 2A Supports the Tumorigenic and Metastatic Potential of Pancreatic Cancer Cells by… DOI 10.1158/0008-5472.can-15-2119↗
- Chi H. Lin · 3 shared papers, 2014–2020 · strength 0.22
- Paper Correction: Inhibition of RAC1 GTPase sensitizes pancreatic cancer cells to γ-irradiation. DOI 10.18632/oncotarget.27450↗
- Paper Biological determinants of radioresistance and their remediation in pancreatic cancer. DOI 10.1016/j.bbcan.2017.02.003↗
- Paper Inhibition of RAC1 GTPase sensitizes pancreatic cancer cells to γ-irradiation. DOI 10.18632/oncotarget.2500↗
- Chitra Palanivel · 1 shared paper, 2022 · strength 0.17
- Jesse L. Cox · 1 shared paper, 2022 · strength 0.17
- Kenneth H. Cowan · 2 shared papers, 2014–2020 · strength 0.16
- Jennifer D. Black · 1 shared paper, 2022 · strength 0.15
- Shelby M. Knoche · 1 shared paper, 2022 · strength 0.15
- Brittany J. Poelaert · 1 shared paper, 2022 · strength 0.15
- Alaina C. Larson · 1 shared paper, 2022 · strength 0.15
- Bailee H. Sliker · 1 shared paper, 2022 · strength 0.15
- Madeline T. Olson · 1 shared paper, 2022 · strength 0.15
- Joyce C. Solheim · 1 shared paper, 2022 · strength 0.15
- Maneesh Jain · 2 shared papers, 2015–2017 · strength 0.11
- Moorthy Palanimuthu Ponnusamy · 2 shared papers, 2015–2016 · strength 0.10
- Satyanarayana Rachagani · 2 shared papers, 2015–2016 · strength 0.10
- Joshua J. Souchek · 1 shared paper, 2017 · strength 0.07
- Sukhwinder Kaur · 1 shared paper, 2017 · strength 0.07
- Michael J. Baine · 1 shared paper, 2017 · strength 0.07
- Chunzi Gao · 1 shared paper, 2016 · strength 0.07
- Bo Han · 1 shared paper, 2016 · strength 0.07
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.